Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2022 Publisher: Daiichi Sankyo UK Limited, 1<sup>st</sup> Floor, Building 4, Uxbridge Business Park, Sanderson Road, Uxbridge, UB8 1DH
Olmetec 10 mg film-coated tablets.
Olmetec 20 mg film-coated tablets.
Olmetec 40 mg film-coated tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablet. Olmetec 10 and 20 mg tablets: White, circular, film-coated tablets with C13 and C14 respectively debossed on one side. Olmetec 40 mg tablets: White, oval, film-coated tablets with C15 debossed on one side. |
Each film-coated tablet contains 10 mg olmesartan medoxomil.
Each film-coated tablet contains 20 mg olmesartan medoxomil.
Each film-coated tablet contains 40 mg olmesartan medoxomil.
Excipient with known effect:
Olmetec 10 mg film-coated tablets: each film-coated tablet contains 61.6 mg lactose monohydrate.
Olmetec 20 mg film-coated tablets: each film-coated tablet contains 123.2 mg lactose monohydrate.
Olmetec 40 mg film-coated tablets: each film-coated tablet contains 246.4 mg lactose monohydrate.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Olmesartan medoxomil |
Olmesartan medoxomil is a potent, orally active, selective angiotensin II receptor (type AT1) antagonist. It is expected to block all actions of angiotensin II mediated by the AT1 receptor, regardless of the source or route of synthesis of angiotensin II. The selective antagonism of the angiotensin II (AT1) receptors results in increases in plasma renin levels and angiotensin I and II concentrations, and some decrease in plasma aldosterone concentrations. |
| List of Excipients |
|---|
|
Tablet core: Cellulose, microcrystalline |
Laminated polyamide/ aluminium/polyvinyl chloride // aluminium blister pack.
Packs of 14, 28, 30, 56, 84, 90, 98 and 10 × 28 film-coated tablets.
Packs with perforated unit dose blisters of 10, 50 and 500 film-coated tablets.
Not all pack sizes may be marketed.
Daiichi Sankyo UK Limited, 1st Floor, Building 4, Uxbridge Business Park, Sanderson Road, Uxbridge, UB8 1DH
Olmetec 10 mg: PL 08265/0015
Olmetec 20 mg: PL 08265/0016
Olmetec 40 mg: PL 08265/0017
22 May 2003/12 August 2007
| Drug | Countries | |
|---|---|---|
| OLMETEC | Albania, Australia, Brazil, Canada, Germany, Ecuador, Spain, Finland, France, Hong Kong, Italy, Japan, Netherlands, Romania, Singapore, Tunisia, Turkey, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
